US senators raise Pfizer and Eli Lilly telehealth prescribing concerns
It is suggested that the platforms could influence patients in favour of the pharma giants or lead to inappropriate prescribing.
Covid-19
FDA revokes EUA for Cue Health’s Covid-19 tests tagging recall as Class II
As mpox spreads, ‘national governments have a moral responsibility to help’
Healthcare cybersecurity risk ‘higher than ever’ due to pandemic
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Q&A: BARDA wants to back tech that can combat multiple infections, says director
MaximBio wins $49.5m US Health award to manufacture Covid-19 tests
Co-Dx seeks FDA emergency use authorization for Covid-19 test
